34. Tăng huyết áp và một số yếu tố liên quan ở bệnh nhân bệnh thận mạn tính chưa điều trị thay thế

Abstract

Hypertension is known as an etiological factor and also a consequence of chronic kidney disease. With the current increasing trend of hypertension, we conducted a study on 157 outpatient patients with chronic kidney disease at Bach Mai Hospital from August 2022 to August 2023 to investigate the prevalence of hypertension and explore associated factors in chronic kidney disease patients without replacement treatment. The results showed that the prevalence of hypertension in the study group was 72.6%, with no difference between males and females. The < 40 age group had prevalences of hypertension of 36.2%, while the 40 - 59 age group and ≥ 60 age group had prevalences of hypertension of 88.5% and 87.9% respectively (p < 0.01). The prevalence of hypertension also differed among the stages of chronic kidney disease: stage 1 had 18.2%, stage 2 had 52.4%, stage 3a had 76.9%, stage 3b had 88.9%, stage 4 had 85.4%, and stage 5 had 90.9% (p < 0.01). Hypertension was significantly associated with an albumin-to-creatinine ratio (ACR) > 30 mg/mmol (odds ratio = 4.38; p < 0.05). Anemia increased the risk of hypertension by 2.12 times (p < 0.05), elevated triglyceride levels increased the risk of hypertension by 5.74 times (p < 0.05), while alcohol consumption increased the risk of hypertension by 2.85 times in the male group (p < 0.05).